TY - JOUR
T1 - Analysis of the Macrophage Scavenger Receptor I Gene in Swedish Hereditary and Sporadic Prostate Cancer
AU - Lindmark, Fredrik
AU - Jonsson, Björn Anders
AU - Bergh, Anders
AU - Stattin, Pär
AU - Zheng, S. Lilly
AU - Meyers, Deborah A.
AU - Xu, Jianfeng
AU - Grönberg, Henrik
PY - 2004/5/1
Y1 - 2004/5/1
N2 - BACKGROUND. The macrophage scavenger receptor 1 (MSR1) gene on chromosome 8p22 was recently reported as a candidate gene for hereditary prostate cancer (HPC). Here, we further elucidate the role of MSR1 in both Swedish families with HPC and in a cohort of unselected prostate cancer. METHODS. DNA samples from 83 Swedish HPC families and 215 unselected population based cases of prostate cancer as well as 425 age-matched controls were genotyped. RESULTS. A total of 18 variants were identified, including 2 exonic, 7 intronic changes, and 9 changes in the 5′- or 3′-uncoding region. Of the two exonic changes, one previously reported truncation mutation was identified, a R293X nonsense mutation. This mutation was found in 2 of the 83 (2.4%) HPC families. The R293X mutation was found more frequently in men with PC (4.9%) than in unaffected men (2.7%), consistent with previous published results, however our results were not significant (P = 0.16). To additionally test for potential association of common sequence variants and increased risk for the disease, five common polymorphisms (PRO3, INDEL1, IVS5-57, P275A, INDEL7) were genotyped in the group of 215 prostate cancer cases and 425 age-matched controls. No association between any of the five common sequence variants and prostate cancer were found. CONCLUSION. Our results suggest that mutations in MSR1 gene might play a role in prostate cancer susceptibility, particularly the R293X mutation. This study warrants further investigations of the role of MSR1 in prostate cancer etiology.
AB - BACKGROUND. The macrophage scavenger receptor 1 (MSR1) gene on chromosome 8p22 was recently reported as a candidate gene for hereditary prostate cancer (HPC). Here, we further elucidate the role of MSR1 in both Swedish families with HPC and in a cohort of unselected prostate cancer. METHODS. DNA samples from 83 Swedish HPC families and 215 unselected population based cases of prostate cancer as well as 425 age-matched controls were genotyped. RESULTS. A total of 18 variants were identified, including 2 exonic, 7 intronic changes, and 9 changes in the 5′- or 3′-uncoding region. Of the two exonic changes, one previously reported truncation mutation was identified, a R293X nonsense mutation. This mutation was found in 2 of the 83 (2.4%) HPC families. The R293X mutation was found more frequently in men with PC (4.9%) than in unaffected men (2.7%), consistent with previous published results, however our results were not significant (P = 0.16). To additionally test for potential association of common sequence variants and increased risk for the disease, five common polymorphisms (PRO3, INDEL1, IVS5-57, P275A, INDEL7) were genotyped in the group of 215 prostate cancer cases and 425 age-matched controls. No association between any of the five common sequence variants and prostate cancer were found. CONCLUSION. Our results suggest that mutations in MSR1 gene might play a role in prostate cancer susceptibility, particularly the R293X mutation. This study warrants further investigations of the role of MSR1 in prostate cancer etiology.
KW - Assciation
KW - Genetic
KW - Macrophage scavenger receptor 1
KW - Prostate cancer
UR - http://www.scopus.com/inward/record.url?scp=1842782766&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1842782766&partnerID=8YFLogxK
U2 - 10.1002/pros.10367
DO - 10.1002/pros.10367
M3 - Article
C2 - 15042613
AN - SCOPUS:1842782766
SN - 0270-4137
VL - 59
SP - 132
EP - 140
JO - Prostate
JF - Prostate
IS - 2
ER -